Last 46 quarters of trend data · Real Estate · REIT - Healthcare Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
EV/EBITDA has expanded 25.8% YoY to 10.7x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 120.00 | — | — | 13.89 | 18.74 | 18.22 | — | 12.76 | 59.04 | 6.40 | 2.54 | 14.02 | — |
| — | — | — | +8.9% | -68.3% | +184.7% | — | -9.0% | — | +80.2% | -86.4% | +8.2% | — | |
| P/S Ratio | 3.60 | 2.78 | 0.61 | 0.85 | 0.74 | 0.95 | 0.87 | 0.82 | 1.10 | 0.83 | 0.82 | 0.82 | 0.86 |
| — | +191.7% | -29.7% | +3.4% | -33.2% | +15.0% | +5.7% | -0.7% | +29.2% | +5.1% | -24.6% | -50.7% | -54.5% | |
| P/B Ratio | 0.18 | 0.89 | 0.18 | 0.22 | 0.19 | 0.23 | 0.21 | 0.19 | 0.24 | 0.19 | 0.19 | 0.19 | 0.19 |
| — | +286.4% | -14.3% | +13.2% | -22.7% | +24.3% | +10.4% | +1.2% | +25.5% | +10.5% | -17.7% | -41.8% | -46.6% | |
| P/FCF | — | 1.22 | — | — | — | 1.51 | 1.89 | 2.33 | 2.54 | 2.22 | 1.88 | 1.99 | 1.90 |
| — | -19.6% | — | — | — | -31.9% | +0.7% | +17.0% | +34.1% | — | — | — | — | |
| EV / EBITDA | 12.91 | 10.67 | 8.59 | 8.51 | 9.28 | 8.48 | 8.20 | 7.95 | 8.37 | 6.93 | 4.98 | 8.02 | 6.05 |
| — | +25.8% | +4.8% | +7.0% | +10.9% | +22.4% | +64.7% | -0.9% | +38.4% | -13.6% | -8.9% | -9.9% | -10.2% | |
| EV / EBIT | 35.06 | — | 23.64 | 18.43 | 17.93 | 17.99 | 36.69 | 20.20 | 25.32 | 15.23 | 18.75 | 15.28 | 20.80 |
| — | — | -35.6% | -8.8% | -29.2% | +18.1% | +95.7% | +32.2% | +21.7% | -19.5% | -13.0% | -41.7% | -4.1% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Global Medical REIT Inc.'s operating margin was 30.7% in Q3 2025, up 8.7 pp QoQ and up 5.2 pp YoY. The trailing four-quarter average of 24.7% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 45.4% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.9% | 42.7% | 78.3% | 78.1% | 79.4% | 78.2% | 78.9% | 78.9% | 81.5% | 79.6% | 100.0% | 79.2% | 99.7% |
| — | -45.4% | -0.7% | -1.1% | -2.6% | -1.7% | -21.1% | -0.3% | -18.3% | -1.9% | +0.3% | -4.7% | -0.3% | |
| Operating Margin | 23.6% | 30.7% | 22.0% | 27.6% | 18.3% | 25.5% | 24.5% | 26.1% | 25.4% | — | 64.2% | 27.6% | 55.3% |
| — | +20.6% | -10.2% | +5.9% | -27.9% | — | -61.8% | -5.4% | -54.0% | — | -7.0% | -3.6% | -6.7% | |
| Net Margin | 4.8% | -11.2% | 1.7% | 10.3% | 8.1% | 9.5% | -4.9% | 6.4% | 1.9% | 12.9% | 36.5% | 5.9% | 5.0% |
| — | -218.0% | +135.0% | +60.4% | +332.8% | -26.6% | -113.5% | +9.2% | -62.8% | -43.1% | +233.4% | -54.5% | -71.0% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 1.1% | -0.9% | 0.1% | 0.7% | 0.5% | 0.6% | -0.3% | 0.4% | 0.1% | 0.7% | 2.1% | 0.3% | 0.3% |
| — | -255.3% | +142.8% | +74.0% | +408.1% | -21.2% | -113.8% | +12.2% | -64.2% | -41.3% | +268.7% | -47.8% | -66.5% | |
| ROA | 0.5% | -0.4% | 0.1% | 0.3% | 0.2% | 0.3% | -0.1% | 0.2% | 0.0% | 0.4% | 1.0% | 0.2% | 0.1% |
| — | -235.3% | +137.7% | +58.6% | +372.9% | -25.4% | -113.7% | +15.3% | -63.2% | -39.9% | +253.4% | -52.3% | -68.9% | |
| ROIC | 2.0% | 0.8% | 0.5% | 0.6% | 0.4% | 0.5% | 0.5% | 0.6% | 0.5% | — | 1.4% | 0.6% | 1.1% |
| — | +38.8% | -2.4% | +5.2% | -21.3% | — | -61.9% | -0.7% | -54.4% | — | -1.1% | +0.8% | -0.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Global Medical REIT Inc.'s Debt/EBITDA ratio is 26.5x, down from 30.7x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 1812.9% YoY to 0.53x, strengthening the short-term liquidity position. Debt/Equity has risen for 9 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.18 | 1.44 | 1.38 | 1.29 | 1.18 | 1.13 | 1.08 | 1.06 | 1.02 | 1.00 | 1.00 | 1.12 | 1.09 |
| — | +27.1% | +28.0% | +21.9% | +15.8% | +13.8% | +8.5% | -5.5% | -5.9% | -6.0% | -3.6% | +22.0% | +19.4% | |
| Debt / EBITDA | 7.36 | 26.52 | 30.74 | 29.32 | 32.38 | 28.40 | 27.75 | 26.96 | 27.16 | 23.93 | 17.23 | 28.21 | 20.67 |
| — | -6.6% | +10.7% | +8.8% | +19.2% | +18.7% | +61.1% | -4.4% | +31.4% | -15.8% | -6.6% | +5.3% | +6.0% | |
| Current Ratio | 0.03 | 0.53 | 1.32 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | — | — | — | 0.05 |
| — | +1812.9% | +4751.3% | -8.7% | +11.5% | — | — | — | -49.1% | — | — | — | -1.4% | |
| Quick Ratio | 0.03 | 0.53 | 1.32 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | — | — | — | 0.05 |
| — | +1812.9% | +4751.3% | -8.7% | +11.5% | — | — | — | -49.1% | — | — | — | -1.4% | |
| Interest Coverage | 1.14 | 1.08 | 1.04 | 1.33 | 0.85 | 1.20 | 1.20 | 1.33 | 1.20 | — | 2.76 | 1.21 | 2.49 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 46 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonGlobal Medical REIT Inc.'s current P/E is 120.0x. The average P/E over the last 2 quarters is 16.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Global Medical REIT Inc.'s current operating margin is 23.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Global Medical REIT Inc.'s business trajectory between earnings reports.